Aurora Cannabis (TSE:ACB) Trading Down 0.7% – Here’s What Happened

Aurora Cannabis Inc. (TSE:ACB)’s share price fell 0.7% during trading on Friday . The company traded as low as C$4.48 and last traded at C$4.57. 309,967 shares traded hands during trading, a decline of 24% from the average session volume of 406,930 shares. The stock had previously closed at C$4.60.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group set a C$10.00 price objective on Aurora Cannabis and gave the stock a “buy” rating in a research note on Tuesday, January 27th. Two equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of C$9.25.

Aurora Cannabis Trading Down 0.7%

The company has a debt-to-equity ratio of 25.02, a current ratio of 3.06 and a quick ratio of 2.48. The stock has a market capitalization of C$270.21 million, a price-to-earnings ratio of -3.05 and a beta of 0.42. The business has a 50 day simple moving average of C$4.73 and a 200-day simple moving average of C$5.53.

Aurora Cannabis (TSE:ACB) last posted its earnings results on Wednesday, February 4th. The company reported C$0.03 earnings per share (EPS) for the quarter. Aurora Cannabis had a negative return on equity of 1.15% and a negative net margin of 1.69%.The firm had revenue of C$94.19 million during the quarter. As a group, equities analysts expect that Aurora Cannabis Inc. will post -0.22 earnings per share for the current year.

Aurora Cannabis Company Profile

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.